Chitosan-based siRNA delivery systems

Journal of Controlled Release

Volumn 172, Issue 1, 2013, Pages 207-218

  Ragelle, Héloïse ^a   Vandermeulen, Gaëlle ^a   Préat, Véronique ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

Chitosan; Delivery barriers; Ligand; Nanoparticles; RNA interference; siRNA

Indexed keywords

BIOLOGICAL FLUIDS; DELIVERY BARRIERS; RNA INTERFERENCE; SIRNA; SMALL INTERFERING RNA (SIRNA); SYSTEMIC DELIVERIES; TARGETING LIGANDS; THERAPEUTIC APPLICATION;

BIOCOMPATIBILITY; LIGANDS; NANOPARTICLES; RNA;

CHITOSAN;

CHITOSAN; CHITOSAN DERIVATIVE; COLLAGEN TYPE 2; CYCLODEXTRIN; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR ALPHA;

BIOLOGICAL ACTIVITY; CELL DENSITY; CELL MEMBRANE; CELL VIABILITY; COMPLEMENT SYSTEM; COMPLEX FORMATION; DEACETYLATION; DRUG DELIVERY SYSTEM; ENDOSOME; ENZYMATIC DEGRADATION; ENZYME DEGRADATION; GENE SILENCING; IMMUNE RESPONSE; IN VITRO GENE TRANSFER; IN VITRO STUDY; IN VIVO STUDY; INTERNALIZATION; INTRATRACHEAL DRUG ADMINISTRATION; IONIC STRENGTH; MOLECULAR WEIGHT; NONHUMAN; OVARY CARCINOMA; PARTICLE SIZE; PRIORITY JOURNAL; REVIEW;

CHITOSAN; DELIVERY BARRIERS; LIGAND; NANOPARTICLES; RNA INTERFERENCE; SIRNA;

ANIMALS; CHITOSAN; GENE TRANSFER TECHNIQUES; HUMANS; MODELS, MOLECULAR; RNA INTERFERENCE; RNA, SMALL INTERFERING;

EID: 84883878577     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2013.08.005     Document Type: Review

References (70)

1. S. Mao, W. Sun, and T. Kissel Chitosan-based formulations for delivery of DNA and siRNA Adv. Drug Deliv. Rev. 62 2010 12 27
2. H. Katas, and H.O. Alpar Development and characterisation of chitosan nanoparticles for siRNA delivery J. Control. Release 115 2006 216 225 (Pubitemid 44559708)
3. X. Liu, K.A. Howard, M. Dong, M.O. Andersen, U.L. Rahbek, M.G. Johnsen, O.C. Hansen, F. Besenbacher, and J. Kjems The influence of polymeric properties on chitosan/siRNA nanoparticle formulation and gene silencing Biomaterials 28 2007 1280 1288 (Pubitemid 44816373)
4. A.L. Jackson, and P.S. Linsley Recognizing and avoiding siRNA off-target effects for target identification and therapeutic application Nat. Rev. Drug Discov. 9 2010 57 67
5. P. Baldrick The safety of chitosan as a pharmaceutical excipient Regul. Toxicol. Pharmacol. 56 2010 290 299
6. N.S. Tapola, M.L. Lyyra, R.M. Kolehmainen, E.S. Sarkkinen, and A.G. Schauss Safety aspects and cholesterol-lowering efficacy of chitosan tablets J. Am. Coll. Nutr. 27 2008 22 30 (Pubitemid 351600519)
7. M. Garcia-Fuentes, and M.J. Alonso Chitosan-based drug nanocarriers: where do we stand? J. Control. Release 161 2012 496 504
8. B.C. Cho, E.H. Kim, H.J. Choi, J.H. Kim, J.K. Roh, H.C. Chung, J.B. Ahn, J.D. Lee, J.T. Lee, N.C. Yoo, and J.H. Sohn A pilot study of trans-arterial injection of 166holmium-chitosan complex for treatment of small hepatocellular carcinoma Yonsei Med. J. 46 2005 799 805 (Pubitemid 43085183)
9. K.A. Howard, U.L. Rahbek, X. Liu, C.K. Damgaard, S.Z. Glud, M.O. Andersen, M.B. Hovgaard, A. Schmitz, J.R. Nyengaard, F. Besenbacher, and J. Kjems RNA interference in vitro and in vivo using a novel chitosan/siRNA nanoparticle system Mol. Ther. 14 2006 476 484 (Pubitemid 44296092)
10. R.L. Kanasty, K.A. Whitehead, A.J. Vegas, and D.G. Anderson Action and reaction: the biological response to siRNA and its delivery vehicles Mol. Ther. 20 2012 513 524
11. Y.K. Oh, and T.G. Park siRNA delivery systems for cancer treatment Adv. Drug Deliv. Rev. 61 2009 850 862
12. D. Fischer, Y. Li, B. Ahlemeyer, J. Krieglstein, and T. Kissel In vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysis Biomaterials 24 2003 1121 1131 (Pubitemid 36069121)
13. B. Ballarin-Gonzalez, and K.A. Howard Polycation-based nanoparticle delivery of RNAi therapeutics: adverse effects and solutions Adv. Drug Deliv. Rev. 64 2012 1717 1729
14. J. Nguyen, and F.C. Szoka Nucleic acid delivery: the missing pieces of the puzzle? Acc. Chem. Res. 45 2012 1153 1162
15. T. Miller, A. Hill, S. Uezguen, M. Weigandt, and A. Goepferich Analysis of immediate stress mechanisms upon injection of polymeric micelles and related colloidal drug carriers: implications on drug targeting Biomacromolecules 13 2012 1707 1718
16. K. Buyens, S.C. De Smedt, K. Braeckmans, J. Demeester, L. Peeters, L.A. van Grunsven, d.J. de Mollerat, X, R. Sawant, V. Torchilin, K. Farkasova, M. Ogris, and N.N. Sanders Liposome based systems for systemic siRNA delivery: stability in blood sets the requirements for optimal carrier design J. Control. Release 158 2012 362 370
17. K. Buyens, B. Lucas, K. Raemdonck, K. Braeckmans, J. Vercammen, J. Hendrix, Y. Engelborghs, S.C. De Smedt, and N.N. Sanders A fast and sensitive method for measuring the integrity of siRNA-carrier complexes in full human serum J. Control. Release 126 2008 67 76
18. K. Raemdonck, T.F. Martens, K. Braeckmans, J. Demeester, and S.C. De Smedt Polysaccharide-based nucleic acid nanoformulations Adv. Drug Deliv. Rev. 2013 10.1016/j.addr.2013.05.002
19. S.K. Lai, Y.Y. Wang, and J. Hanes Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues Adv. Drug Deliv. Rev. 61 2009 158 171
20. A.D. Sezer, and E. Cevher Topical drug delivery using chitosan nano- and microparticles Expert Opin. Drug Deliv. 9 2012 1129 1146
21. T.M. Allen Ligand-targeted therapeutics in anticancer therapy Nat. Rev. Cancer 2 2002 750 763 (Pubitemid 37328910)
22. A. Akinc, M. Thomas, A.M. Klibanov, and R. Langer Exploring polyethylenimine-mediated DNA transfection and the proton sponge hypothesis J. Gene Med. 7 2005 657 663 (Pubitemid 40744532)
23. R.V. Benjaminsen, M.A. Mattebjerg, J.R. Henriksen, S.M. Moghimi, and T.L. Andresen The possible "proton sponge " effect of polyethylenimine (PEI) does not include change in lysosomal pH Mol. Ther. 21 2013 149 157
24. T.H. Kim, S.I. Kim, T. Akaike, and C.S. Cho Synergistic effect of poly(ethylenimine) on the transfection efficiency of galactosylated chitosan/DNA complexes J. Control. Release 105 2005 354 366 (Pubitemid 40941999)
25. W.F. Lai, and M.C. Lin Nucleic acid delivery with chitosan and its derivatives J. Control. Release 134 2009 158 168
26. J.C. Fernandes, X. Qiu, F.M. Winnik, M. Benderdour, X. Zhang, K. Dai, and Q. Shi Low molecular weight chitosan conjugated with folate for siRNA delivery in vitro: optimization studies Int. J. Nanomedicine 7 2012 5833 5845
27. M. Alameh, D. Dejesus, M. Jean, V. Darras, M. Thibault, M. Lavertu, M.D. Buschmann, and A. Merzouki Low molecular weight chitosan nanoparticulate system at low N:P ratio for nontoxic polynucleotide delivery Int. J. Nanomedicine 7 2012 1399 1414
28. F. Kong, G. Liu, B. Sun, S. Zhou, A. Zuo, R. Zhao, and D. Liang Phosphorylatable short peptide conjugated low molecular weight chitosan for efficient siRNA delivery and target gene silencing Int. J. Pharm. 422 2012 445 453
29. P. Holzerny, B. Ajdini, W. Heusermann, K. Bruno, M. Schuleit, L. Meinel, and M. Keller Biophysical properties of chitosan/siRNA polyplexes: profiling the polymer/siRNA interactions and bioactivity J. Control. Release 157 2012 297 304
30. J. Malmo, H. Sorgard, K.M. Varum, and S.P. Strand siRNA delivery with chitosan nanoparticles: molecular properties favoring efficient gene silencing J. Control. Release 158 2012 261 268
31. Y. Luo, X. Zhai, C. Ma, P. Sun, Z. Fu, W. Liu, and J. Xu An inhalable beta(2)-adrenoceptor ligand-directed guanidinylated chitosan carrier for targeted delivery of siRNA to lung J. Control. Release 162 2012 28 36
32. M. Ravina, E. Cubillo, D. Olmeda, R. Novoa-Carballal, E. Fernandez-Megia, R. Riguera, A. Sanchez, A. Cano, and M.J. Alonso Hyaluronic acid/chitosan-g-poly(ethylene glycol) nanoparticles for gene therapy: an application for pDNA and siRNA delivery Pharm. Res. 27 2010 2544 2555
33. T. Rojanarata, P. Opanasopit, S. Techaarpornkul, T. Ngawhirunpat, and U. Ruktanonchai Chitosan-thiamine pyrophosphate as a novel carrier for siRNA delivery Pharm. Res. 25 2008 2807 2814
34. S. Techaarpornkul, S. Wongkupasert, P. Opanasopit, A. Apirakaramwong, J. Nunthanid, and U. Ruktanonchai Chitosan-mediated siRNA delivery in vitro: effect of polymer molecular weight, concentration and salt forms AAPS PharmSciTech 11 2010 64 72
35. J. Malmo, K.M. Varum, and S.P. Strand Effect of chitosan chain architecture on gene delivery: comparison of self-branched and linear chitosans Biomacromolecules 12 2011 721 729
36. M. Jean, M. Alameh, J.D. De, M. Thibault, M. Lavertu, V. Darras, M. Nelea, M.D. Buschmann, and A. Merzouki Chitosan-based therapeutic nanoparticles for combination gene therapy and gene silencing of in vitro cell lines relevant to type 2 diabetes Eur. J. Pharm. Sci. 45 2012 138 149
37. K.A. Howard, S.R. Paludan, M.A. Behlke, F. Besenbacher, B. Deleuran, and J. Kjems Chitosan/siRNA nanoparticle-mediated TNF-alpha knockdown in peritoneal macrophages for anti-inflammatory treatment in a murine arthritis model Mol. Ther. 17 2009 162 168
38. A.M. Ji, D. Su, O. Che, W.S. Li, L. Sun, Z.Y. Zhang, B. Yang, and F. Xu Functional gene silencing mediated by chitosan/siRNA nanocomplexes Nanotechnology 20 2009 405103
39. V. Dehousse, N. Garbacki, S. Jaspart, D. Castagne, G. Piel, A. Colige, and B. Evrard Comparison of chitosan/siRNA and trimethylchitosan/siRNA complexes behaviour in vitro Int. J. Biol. Macromol. 46 2010 342 349
40. D. Jere, H.L. Jiang, Y.K. Kim, R. Arote, Y.J. Choi, C.H. Yun, M.H. Cho, and C.S. Cho Chitosan-graft-polyethylenimine for Akt1 siRNA delivery to lung cancer cells Int. J. Pharm. 378 2009 194 200
41. S.M. Noh, M.O. Park, G. Shim, S.E. Han, H.Y. Lee, J.H. Huh, M.S. Kim, J.J. Choi, K. Kim, I.C. Kwon, J.S. Kim, K.H. Baek, and Y.K. Oh Pegylated poly-l-arginine derivatives of chitosan for effective delivery of siRNA J. Control. Release 145 2010 159 164
42. S. Al-Qadi, M. Alatorre-Meda, E.M. Zaghloul, P. Taboada, and C. Remunan-Lopez Chitosan-hyaluronic acid nanoparticles for gene silencing: the role of hyaluronic acid on the nanoparticles' formation and activity Colloids Surf. B Biointerfaces 103C 2012 615 623
43. M. Malhotra, C. Tomaro-Duchesneau, and S. Prakash Synthesis of TAT peptide-tagged PEGylated chitosan nanoparticles for siRNA delivery targeting neurodegenerative diseases Biomaterials 34 2013 1270 1280
44. Z.X. Liao, Y.C. Ho, H.L. Chen, S.F. Peng, C.W. Hsiao, and H.W. Sung Enhancement of efficiencies of the cellular uptake and gene silencing of chitosan/siRNA complexes via the inclusion of a negatively charged poly(gamma-glutamic acid) Biomaterials 31 2010 8780 8788
45. D.W. Lee, K.S. Yun, H.S. Ban, W. Choe, S.K. Lee, and K.Y. Lee Preparation and characterization of chitosan/polyguluronate nanoparticles for siRNA delivery J. Control. Release 139 2009 146 152
46. J. Lee, K.S. Yun, C.S. Choi, S.H. Shin, H.S. Ban, T. Rhim, S.K. Lee, and K.Y. Lee T cell-specific siRNA delivery using antibody-conjugated chitosan nanoparticles Bioconjug. Chem. 30 2012 1174 1180
47. Y. Ping, C. Liu, Z. Zhang, K.L. Liu, J. Chen, and J. Li Chitosan-graft-(PEI-beta-cyclodextrin) copolymers and their supramolecular PEGylation for DNA and siRNA delivery Biomaterials 32 2011 8328 8341
48. H.D. Han, L.S. Mangala, J.W. Lee, M.M. Shahzad, H.S. Kim, D. Shen, E.J. Nam, E.M. Mora, R.L. Stone, C. Lu, S.J. Lee, J.W. Roh, A.M. Nick, G. Lopez-Berestein, and A.K. Sood Targeted gene silencing using RGD-labeled chitosan nanoparticles Clin. Cancer Res. 16 2010 3910 3922
49. V. Dehousse, N. Garbacki, A. Colige, and B. Evrard Development of pH-responsive nanocarriers using trimethylchitosans and methacrylic acid copolymer for siRNA delivery Biomaterials 31 2010 1839 1849
50. J. Zhang, C. He, C. Tang, and C. Yin Ternary polymeric nanoparticles for oral siRNA delivery Pharm. Res. 30 2013 1228 1239
51. A.K. Varkouhi, R.J. Verheul, R.M. Schiffelers, T. Lammers, G. Storm, and W.E. Hennink Gene silencing activity of siRNA polyplexes based on thiolated N, N, N-trimethylated chitosan Bioconjug. Chem. 21 2010 2339 2346
52. M.S. Huh, S.Y. Lee, S. Park, S. Lee, H. Chung, S. Lee, Y. Choi, Y.K. Oh, J.H. Park, S.Y. Jeong, K. Choi, K. Kim, and I.C. Kwon Tumor-homing glycol chitosan/polyethylenimine nanoparticles for the systemic delivery of siRNA in tumor-bearing mice J. Control. Release 144 2010 134 143
53. S.J. Lee, M.S. Huh, S.Y. Lee, S. Min, S. Lee, H. Koo, J.U. Chu, K.E. Lee, H. Jeon, Y. Choi, K. Choi, Y. Byun, S.Y. Jeong, K. Park, K. Kim, and I.C. Kwon Tumor-homing poly-siRNA/glycol chitosan self-cross-linked nanoparticles for systemic siRNA delivery in cancer treatment Angew. Chem. Int. Ed. Engl. 51 2012 7203 7207
54. O. Veiseh, F.M. Kievit, H. Mok, J. Ayesh, C. Clark, C. Fang, M. Leung, H. Arami, J.O. Park, and M. Zhang Cell transcytosing poly-arginine coated magnetic nanovector for safe and effective siRNA delivery Biomaterials 32 2011 5717 5725
55. E.J. Kim, G. Shim, K. Kim, I.C. Kwon, Y.K. Oh, and C.K. Shim Hyaluronic acid complexed to biodegradable poly l-arginine for targeted delivery of siRNAs J. Gene Med. 11 2009 791 803
56. O.M. Merkel, D. Librizzi, A. Pfestroff, T. Schurrat, K. Buyens, N.N. Sanders, S.C. De Smedt, M. Behe, and T. Kissel Stability of siRNA polyplexes from poly(ethylenimine) and poly(ethylenimine)-g-poly(ethylene glycol) under in vivo conditions: effects on pharmacokinetics and biodistribution measured by Fluorescence Fluctuation Spectroscopy and Single Photon Emission Computed Tomography (SPECT) imaging J. Control. Release 138 2009 148 159
57. M.P. Patel, R.R. Patel, and J.K. Patel Chitosan mediated targeted drug delivery system: a review J. Pharm. Pharm. Sci. 13 2010 536 557
58. P.M. Valencia, M.H. Hanewich-Hollatz, W. Gao, F. Karim, R. Langer, R. Karnik, and O.C. Farokhzad Effects of ligands with different water solubilities on self-assembly and properties of targeted nanoparticles Biomaterials 32 2011 6226 6233
59. F. Danhier, B.A. Le, and V. Preat RGD-based strategies to target alpha(v) beta(3) integrin in cancer therapy and diagnosis Mol. Pharm. 9 2012 2961 2973
60. X. Zhao, H. Li, and R.J. Lee Targeted drug delivery via folate receptors Expert Opin. Drug Deliv. 5 2008 309 319 (Pubitemid 351454380)
61. K. Buyens, M. Meyer, E. Wagner, J. Demeester, S.C. De Smedt, and N.N. Sanders Monitoring the disassembly of siRNA polyplexes in serum is crucial for predicting their biological efficacy J. Control. Release 141 2010 38 41
62. D. Peer, and J. Lieberman Special delivery: targeted therapy with small RNAs Gene Ther. 18 2011 1127 1133
63. J.C. Burnett, J.J. Rossi, and K. Tiemann Current progress of siRNA/shRNA therapeutics in clinical trials Biotechnol. J. 6 2011 1130 1146
64. E. Salva, L. Kabasakal, F. Eren, N. Ozkan, F. Cakalagaoglu, and J. Akbuga Local delivery of chitosan/VEGF siRNA nanoplexes reduces angiogenesis and growth of breast cancer in vivo Nucleic Acid Ther. 22 2012 40 48
65. A. Bernkop-Schnurch, and S. Dunnhaupt Chitosan-based drug delivery systems Eur. J. Pharm. Biopharm. 81 2012 463 469
66. E.J. Nielsen, J.M. Nielsen, D. Becker, A. Karlas, H. Prakash, S.Z. Glud, J. Merrison, F. Besenbacher, T.F. Meyer, J. Kjems, and K.A. Howard Pulmonary gene silencing in transgenic EGFP mice using aerosolised chitosan/siRNA nanoparticles Pharm. Res. 27 2010 2520 2527
67. I. Nawroth, J. Alsner, M.A. Behlke, F. Besenbacher, J. Overgaard, K.A. Howard, and J. Kjems Intraperitoneal administration of chitosan/DsiRNA nanoparticles targeting TNFalpha prevents radiation-induced fibrosis Radiother. Oncol. 97 2010 143 148
68. I. Nawroth, J. Alsner, B.W. Deleuran, F. Dagnaes-Hansen, C. Yang, M.R. Horsman, J. Overgaard, K.A. Howard, J. Kjems, and S. Gao Peritoneal macrophages mediated delivery of chitosan/siRNA nanoparticle to the lesion site in a murine radiation-induced fibrosis model Acta Oncol. 2012 10.3109/0284186X.2012.726373
69. B. Ballarin-Gonzalez, F. Dagnaes-Hansen, R.A. Fenton, S. Gao, S. Hein, M. Dong, J. Kjems, and K.A. Howard Protection and Systemic Translocation of siRNA Following Oral Administration of Chitosan/siRNA Nanoparticles Mol. Ther. Nucleic Acids 2 2013 e76
70. D.E. Owens III, and N.A. Peppas Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles Int. J. Pharm. 307 2006 93 102 (Pubitemid 41773257)